Bell RM - Search Results

1

Nitric oxide as a mediator of delayed pharmacological (A(1) receptor triggered) preconditioning; is eNOS masquerading as iNOS?

Bell RM, Smith CC, Yellon DM. Bell RM, et al. Cardiovasc Res. 2002 Feb 1;53(2):405-13. doi: 10.1016/s0008-6363(01)00472-2. Cardiovasc Res. 2002. PMID: 11827691

2

Molecular mechanisms of preconditioning: therapeutic implications.

Bell RM, Yellon DM. Bell RM, et al. Rev Port Cardiol. 1998 Oct;17 Suppl 2:II49-61. Rev Port Cardiol. 1998. PMID: 9835782 Review.

3

The contribution of endothelial nitric oxide synthase to early ischaemic preconditioning: the lowering of the preconditioning threshold. An investigation in eNOS knockout mice.

Bell RM, Yellon DM. Bell RM, et al. Cardiovasc Res. 2001 Nov;52(2):274-80. doi: 10.1016/s0008-6363(01)00394-7. Cardiovasc Res. 2001. PMID: 11684075

4

PI3 kinase and not p42/p44 appears to be implicated in the protection conferred by ischemic preconditioning.

Mocanu MM, Bell RM, Yellon DM. Mocanu MM, et al. Among authors: bell rm. J Mol Cell Cardiol. 2002 Jun;34(6):661-8. doi: 10.1006/jmcc.2002.2006. J Mol Cell Cardiol. 2002. PMID: 12054853

5

The carboxyl-terminal activation domain of the STAT-1 transcription factor enhances ischemia/reperfusion-induced apoptosis in cardiac myocytes.

Stephanou A, Scarabelli TM, Townsend PA, Bell R, Yellon D, Knight RA, Latchman DS. Stephanou A, et al. FASEB J. 2002 Nov;16(13):1841-3. doi: 10.1096/fj.02-0150fje. Epub 2002 Sep 5. FASEB J. 2002. Retraction in: FASEB J. 2018 Apr;32(4):2315. doi: 10.1096/fj.02-0150fjeRET PMID: 12223448 Retracted.

6

The cardioprotective and mitochondrial depolarising properties of exogenous nitric oxide in mouse heart.

Bell RM, Maddock HL, Yellon DM. Bell RM, et al. Cardiovasc Res. 2003 Feb;57(2):405-15. doi: 10.1016/s0008-6363(02)00675-2. Cardiovasc Res. 2003. PMID: 12566113

7

Atorvastatin, administered at the onset of reperfusion, and independent of lipid lowering, protects the myocardium by up-regulating a pro-survival pathway.

Bell RM, Yellon DM. Bell RM, et al. J Am Coll Cardiol. 2003 Feb 5;41(3):508-15. doi: 10.1016/s0735-1097(02)02816-4. J Am Coll Cardiol. 2003. PMID: 12575984 Free article.

8

Bradykinin limits infarction when administered as an adjunct to reperfusion in mouse heart: the role of PI3K, Akt and eNOS.

Bell RM, Yellon DM. Bell RM, et al. J Mol Cell Cardiol. 2003 Feb;35(2):185-93. doi: 10.1016/s0022-2828(02)00310-3. J Mol Cell Cardiol. 2003. PMID: 12606259

9

Reperfusion kinase phosphorylation is essential but not sufficient in the mediation of pharmacological preconditioning: Characterisation in the bi-phasic profile of early and late protection.

Bell RM, Clark JE, Hearse DJ, Shattock MJ. Bell RM, et al. Cardiovasc Res. 2007 Jan 1;73(1):153-63. doi: 10.1016/j.cardiores.2006.10.013. Epub 2006 Oct 26. Cardiovasc Res. 2007. PMID: 17126307

10

There is more to life than revascularization: therapeutic targeting of myocardial ischemia/reperfusion injury.

Bell RM, Yellon DM. Bell RM, et al. Cardiovasc Ther. 2011 Dec;29(6):e67-79. doi: 10.1111/j.1755-5922.2010.00190.x. Epub 2010 Jul 14. Cardiovasc Ther. 2011. PMID: 20645988 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

335 results

Search Page

Filters